Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis

  Free Subscription

Articles published in
Gastroenterology
    August 2025
  1. KUSHNER T, Cohen SM, Ahn J, Wong RJ, et al
    AGA Clinical Practice Update on Management of Hepatitis Delta: Commentary.
    Gastroenterology. 2025 Aug 20:S0016-5085(25)05842.
    >> Share

    July 2025
  2. JI Y, Le Bert N, Lai-Hung Wong G, Douglas MW, et al
    The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune Responses.
    Gastroenterology. 2025;169:136-149.
    >> Share

    February 2025
  3. ALI FS, Nguyen MH, Hernaez R, Huang DQ, et al
    AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.
    Gastroenterology. 2025;168:267-284.
    >> Share

    January 2025
  4. KUMAR N, Chaudhary A
    Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program".
    Gastroenterology. 2025 Jan 30:S0016-5085(25)00326.
    >> Share

    November 2024
  5. MEZZACAPPA C
    Gastro Digest: The Revised REACH-B Model Predicts Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05756.
    >> Share

  6. ZHANG X, Klohn M, Ouwerkerk-Mahadevan S, Jagst M, et al
    A pan-genotypic hepatitis E virus replication inhibitor with high potency in a rat infection model.
    Gastroenterology. 2024 Nov 22:S0016-5085(24)05696.
    >> Share

    August 2024
  7. PREMKUMAR M, Dhiman RK, Duseja A, Mehtani R, et al
    Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
    Gastroenterology. 2024 Aug 22:S0016-5085(24)05359.
    >> Share

  8. TRAN CS, Kersten J, Yan J, Breinig M, et al
    Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells.
    Gastroenterology. 2024;167:522-537.
    >> Share

    July 2024
  9. MEZZACAPPA C
    Gastro Digest: Integrated telemedicine to treat HCV through opioid treatment programs.
    Gastroenterology. 2024 Jul 16:S0016-5085(24)05213.
    >> Share

    June 2024
  10. LIAW YF
    Prediction of Clinical Relapse and HBsAg Loss After Cessation of Anti-HBV Therapy.
    Gastroenterology. 2024;166:1193.
    >> Share

    May 2024
  11. GOUTTENOIRE J, Neyts J
    A hepatitis E virus infection model in the Mongolian Gerbil: ready for antiviral and vaccine studies.
    Gastroenterology. 2024 May 23:S0016-5085(24)04938.
    >> Share

    April 2024
  12. GUTIERREZ SANCHEZ LH, Ibrahim SH
    Severe Acute Hepatitis of Unknown Etiology in Children: New Virus or Immune Dysregulation.
    Gastroenterology. 2024 Apr 23:S0016-5085(24)00481.
    >> Share

  13. LIU T, He Q, Yang X, Li Y, et al
    An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus Genotype 1 Infection.
    Gastroenterology. 2024 Apr 5:S0016-5085(24)00364.
    >> Share

    February 2024
  14. TRIVEDI PJ, Hirschfield GM, Adams DH, Vierling JM, et al
    Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts.
    Gastroenterology. 2024 Feb 9:S0016-5085(24)00165.
    >> Share

  15. HERMS Q, Fuster-Anglada C, Juanola A
    Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
    Gastroenterology. 2024 Feb 4:S0016-5085(24)00133.
    >> Share

    January 2024
  16. PISATURO M, Alessio L, de Pascalis S, Messina V, et al
    A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy.
    Gastroenterology. 2024;166:191-193.
    >> Share

    December 2023
  17. LAI L, Rao C, Liu H
    An Unusual Cause of Ascites in a Patient with Hepatitis B.
    Gastroenterology. 2023 Dec 7:S0016-5085(23)05593.
    >> Share

    November 2023
  18. LENS S
    Successful HCV viral cure is not the end of the story.
    Gastroenterology. 2023 Nov 3:S0016-5085(23)05205.
    >> Share

    October 2023
  19. ZHENG D, Fang Z, Sun J
    Which is more clinically relevant: end-of-treatment or off-treatment predictors of hepatitis B relapse and surface antigen loss?
    Gastroenterology. 2023 Oct 25:S0016-5085(23)05196.
    >> Share

  20. LIM SG, Tan YC
    Additional Measures After Stopping Nucleoside Analogues in HbeAg-Negative Chronic Hepatitis B: Better But Not Enough.
    Gastroenterology. 2023 Oct 12:S0016-5085(23)05132.
    >> Share

  21. DARA L, Ghabril M, Phillips E, Kleiner D, et al
    A 68-year-old woman with unexplained liver enzyme elevation and active chronic hepatitis: Beware of drug induced autoimmune like hepatitis.
    Gastroenterology. 2023 Oct 3:S0016-5085(23)05078.
    >> Share

    September 2023
  22. SONNEVELD MJ, Chiu SM, Park JY, Brakenhoff SM, et al
    Hepatitis B Virus DNA and Hepatitis B e Antigen Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and Hepatitis B Antigen Loss in Hepatitis B e Antigen-Negative Patients Who Discontinued Antiviral Therapy.
    Gastroenterology. 2023 Sep 26:S0016-5085(23)05068.
    >> Share

    August 2023
  23. CONGLY SE, Brahmania M, Coffin CS
    Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset.
    Gastroenterology. 2023 Aug 17:S0016-5085(23)04891.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016